| [1] |
Xu X, Ning Y, Shang W, et al. Analysis of 4931 renal biopsy data in central China from 1994 to 2014 [J]. Ren Fail, 2016, 38(7):1021-1030.
|
| [2] |
Couser WG, Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis [J]. Am J Kidney Dis, 1994, 23(2):193-198.
|
| [3] |
Kashgarian M, Sterzel RB. The pathobiology of the mesangium [J]. Kidney Int, 1992, 41(3):524-529.
|
| [4] |
Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases [J]. Nat Rev Mol Cell Biol, 2013, 14(8):518-528.
|
| [5] |
Ahn JD, Morishita R, Kaneda Y, et al. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo [J]. Gene Ther, 2004, 11(11):916-923.
|
| [6] |
Tomita N, Kim JY, Gibbons GH, et al. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis [J]. Int J Mol Med, 2004, 13(5):629-636.
|
| [7] |
Kang JH, Chae YM, Park KK, et al. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo [J]. J Cell Biochem, 2008, 103(2):663-674.
|
| [8] |
Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins [J]. Mol Cell Biol, 1993, 13(5):2776-2786.
|
| [9] |
McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases [J]. Physiol Rev, 2010, 90(4):1337-1381.
|
| [10] |
Gao X, Wu G, Gu X, et al. Kruppel-like factor 15 modulates renal interstitial fibrosis by ERK/MAPK and JNK/MAPK pathways regulation [J]. Kidney Blood Press Res, 2013, 37(6):631-640.
|
| [11] |
Gu X, Xu D, Fu L, et al. KLF 15 works as an early anti-fibrotic transcriptional regulator in Ang II-induced renal fibrosis via down-regulation of CTGF expression [J]. Kidney Blood Press Res, 2017, 42(6):999-1012.
|
| [12] |
Mallipattu SK, Guo Y, Revelo MP, et al. Kruppel-like factor 15 mediates glucocorticoid-induced restoration of podocyte differentiation markers [J]. J Am Soc Nephrol, 2017, 28(1):166-184.
|
| [13] |
Hong Q, Li C, Xie Y, et al. Kruppel-like factor-15 inhibits the proliferation of mesangial cells [J]. Cell Physiol Biochem, 2012, 29(5-6):893-904.
|
| [14] |
Zhang J, Zhong HB, Lin Y, et al. KLF15 suppresses cell proliferation and extracellular matrix expression in mesangial cells under high glucose [J]. Int J Clin Exp Med, 2015, 8(11):20330-20336.
|
| [15] |
Gao L, Qiu H, Liu J, et al. KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker [J]. Oncotarget, 2017, 8(66):109952-109961.
|
| [16] |
Sun C, Ma P, Wang Y, et al. KLF15 inhibits cell proliferation in gastric cancer cells via up-regulating CDKN1A/p21 and CDKN1C/p57 expression [J]. Dig Dis Sci, 2017, 62(6):1518-1526.
|
| [17] |
Wang K, Ren Y, Liu Y, et al. miR-4262 promotes proliferation and invasion of human breast cancer cells through directly targeting KLF6 and KLF15 [J]. Oncol Res, 2017, 25(2):277-283.
|
| [18] |
Elnitski L, Jin VX, Farnham PJ, et al. Locating mammalian transcription factor binding sites: a survey of computational and experimental techniques [J]. Genome Res, 2006, 16(12):1455-1464.
|
| [19] |
Klein RH, Hu W, Kashgari G, et al. Characterization of enhancers and the role of the transcription factor KLF7 in regulating corneal epithelial differentiation [J]. J Biol Chem, 2017, 292(46):18937-18950.
|
| [20] |
Ying M, Tilghman J, Wei Y, et al. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin alpha6 inhibition [J]. J Biol Chem, 2014, 289(47):32742-32756.
|
| [21] |
Park PJ. ChIP-seq: advantages and challenges of a maturing technology [J]. Nat Rev Genet, 2009, 10(10):669-680.
|